Las Vegas, NV -- (SBWIRE) -- 01/16/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Idera Pharmaceuticals Inc (NASDAQ:IDRA), Novavax, Inc. (NASDAQ:NVAX), DCT Industrial Trust Inc. (NYSE:DCT), Peregrine Pharmaceuticals (NASDAQ:PPHM).
Idera Pharmaceuticals Inc (NASDAQ:IDRA) ended its recent business day with the tumbled of -8.90% and closed at the price of $4.40 after opening at $4.84. The stock traded during its last trading session with the total volume of 3.07 million shares, as compared to its average volume of 2.63 million shares. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Has IDRA Found The Bottom And Ready To Gain Momentum? Find Out Here
Novavax, Inc. (NASDAQ:NVAX) remained among the day bearish -1.80% and traded with volume of 5.68 million shares in the last session, as compared to average volume of 6.54 million shares. In comparison with 52 week range of $1.68 - $6.25, it faced lowest price of $5.87 during the last trading session whereas its day highest price was $6.25. The company’s total market capitalization is $1.25 billion, along with 208.51 million shares outstanding. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases.
Why Should Investors Buy NVAX After the Recent Fall? Just Go Here and Find Out
DCT Industrial Trust Inc. (NYSE:DCT) showed 7.51 million shares in volume during the last trading session, while the average trading volume remained 4.27 million shares. The stock kicked off its trading session at $6.97 and closed at $7.08 after rallied 1.72%. DCT Industrial Trust Inc. operates as a publicly owned real estate investment trust. The firm provides its services to companies.
Why Should Investors Buy DCT After The Recent Gain? Just Go Here and Find Out
Peregrine Pharmaceuticals (NASDAQ:PPHM) stock traded during its last trading session with the total traded volume of 2.93 million shares versus its average volume of 2.96 million shares. The company opened its trade at the price of $1.76 and its closing price was $1.72 stock not showed any percentage change and stayed at 0.00% for the day. Peregrine Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of monoclonal antibodies focused on the treatment and diagnosis of cancer.
Can Investors Bet on PPHM after this News update? Find out in this Research Report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)